According to GuruFocus Insider Data, these are the largest CFO buys during the past week.
Pacira Pharmaceuticals Inc. (PCRX, Financial): CFO James S Scibetta Bought 5,000 Shares
CFO of Pacira Pharmaceuticals Inc. (PCRX) James S Scibetta bought 5,000 shares on 02/15/2011 at an average price of $7.04. Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers.
President and CEO David M Stack, CFO James S Scibetta, and 10% Owner Bioventures Iv Qp Lp Mpm bought shares of PCRX stock.
MEADOWBROOK INSURANCE (MIG, Financial): SVP - CFO Karen M Spaun Bought 5,000 Shares
SVP - CFO of MEADOWBROOK INSURANCE (MIG) Karen M Spaun bought 5,000 shares on 02/22/2011 at an average price of $10.2. MEADOWBROOK INS GROUP INC, through its subsidiaries, is engaged primarily in developing and managing Alternative Market risk management programs for defined client groups and their members. Meadowbrook Insurance has a market cap of $546.1 million; its shares were traded at around $10.26 with a P/E ratio of 9.7 and P/S ratio of 0.7. The dividend yield of Meadowbrook Insurance stocks is 1.6%. Meadowbrook Insurance had an annual average earning growth of 10.2% over the past 5 years.
Meadowbrook Insurance Group, Inc. reported improved full year and fourth quarter 2010 results. Meadowbrook Insurance Group, Inc. reported that net operating income for the year ended December 31, 2010increased 8.8% to $58.2 million, or $1.07 per diluted share, up from $53.5 million, or $0.93 per diluted share, for the comparable prior year period. Net income increased 13.4% to $59.7 million, or $1.10 per diluted share, compared to $52.7 million, or $0.92 per diluted share, in 2009.
Mutual Fund and Other Gurus that owns MIG: Chuck Royce of Royce& Associates, John Keeley of Keeley Fund Management, Mario Gabelli of GAMCO Investors.
SVP - CFO Karen M Spaun bought shares of MIG stock.
Director Jeffrey A Maffett, Director Merton J Segal, and SVP - Chief Actuary Stephen A Belden sold shares of MIG stock.
UGI Corp. (UGI, Financial): CFO Robert C Flexon Bought 5,000 Shares
CFO of UGI Corp. (UGI) Robert C Flexon bought 5,000 shares on 02/16/2011 at an average price of $32.06. UGI Corporation is a holding company that operates propanedistribution, gas and electric utility, energy marketing and related businesses through subsidiaries. Ugi Corp. has a market cap of $3.54 billion; its shares were traded at around $32.01 with a P/E ratio of 13.5 and P/S ratio of 0.6. The dividend yield of Ugi Corp. stocks is 3.1%. Ugi Corp. had an annual average earning growth of 9.4% over the past 10 years. GuruFocus rated Ugi Corp. the business predictability rank of 3-star.
Hedge Fund Gurus that owns UGI: Bruce Kovner of Caxton Associates, George Soros of Soros Fund Management LLC, Jim Simons of Renaissance Technologies LLC. Mutual Fund and Other Gurus that owns UGI: Diamond Hill Capital of Diamond Hill Capital Management Inc, Chuck Royce of Royce& Associates, Jeremy Grantham of GMO LLC, Mario Gabelli of GAMCO Investors.
President & CEO of AmeriGas Eugene V N Bissell, Chairman & CEO Lon R Greenberg, and President & COO John L Walsh sold shares of UGI stock.
GLATFELTER (GLT, Financial): SVP, CFO John P Jacunski Bought 5,000 Shares
SVP, CFO of GLATFELTER (GLT) John P Jacunski bought 5,000 shares on 02/23/2011 at an average price of $11.2. Glatfelter is a paper manufacturing company that manufactures printing papers and tobacco and other specialty papers. Glatfelter has a market cap of $561.8 million; its shares were traded at around $12.25 with a P/E ratio of 13.8 and P/S ratio of 0.4. The dividend yield of Glatfelter stocks is 2.9%. Glatfelter had an annual average earning growth of 0.3% over the past 10 years.
Glatfelter reported its financial results for the quarter and year ended December 31, 2010, including adjusted earnings of $0.31 per diluted share in the fourth quarter of 2010, compared to $0.33 per diluted share a year ago. Consolidated net sales for the 2010 fourth quarter totaled $376.2 million, a 24.9 percent increase compared with $301.1 million for the fourth quarter of 2009. On a GAAP basis, the Company reported net income of $15.3 million or $0.33 per diluted share, for the fourth quarter of 2010, compared with net income of $46.0 million or $1.00 per diluted share in the same quarter a year ago.
Hedge Fund Gurus that owns GLT: Paul Tudor Jones of The Tudor Group, Jim Simons of Renaissance Technologies LLC. Mutual Fund and Other Gurus that owns GLT: Third Avenue Management, Donald Smith of Donald Smith & Co.
SVP, CFO John P Jacunski and V. P. Global Supply Chain Mark A Sullivan bought shares of GLT stock.
Innospec Inc. (IOSP, Financial): Exec VP & CFO Ian Cleminson Bought 5,014 Shares
Exec VP & CFO of Innospec Inc. (IOSP) Ian Cleminson bought 5,014 shares during the past week at an average price of $26.94. Octel Corp. is a major manufacturer and distributor of fuel additives and other specialty chemicals. Innospec Inc. has a market cap of $642 million; its shares were traded at around $26.96 with a P/E ratio of 9.7 and P/S ratio of 0.9.
Innospec Inc. announced its financial results for the fourth quarter and full year ended December 31, 2010. Total net sales for the fourth quarter were $177.3 million, an 8% increase from $164.2 million in the corresponding period last year. Net income was $24.3 million, or $0.98 per diluted share, compared with a net loss of ($0.3) million, or ($0.01) per share, a year ago.
Hedge Fund Gurus that owns IOSP: Jim Simons of Renaissance Technologies LLC. Mutual Fund and Other Gurus that owns IOSP: Chuck Royce of Royce& Associates.
Exec VP & CFO Ian Cleminson, Group Financial Controller Mark Bracewell, and Exec VP, Business Operations Philip John Boon bought shares of IOSP stock.
For the complete list of stocks that bought by their CFOs, go to: Insider Buys.
Pacira Pharmaceuticals Inc. (PCRX, Financial): CFO James S Scibetta Bought 5,000 Shares
CFO of Pacira Pharmaceuticals Inc. (PCRX) James S Scibetta bought 5,000 shares on 02/15/2011 at an average price of $7.04. Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers.
President and CEO David M Stack, CFO James S Scibetta, and 10% Owner Bioventures Iv Qp Lp Mpm bought shares of PCRX stock.
MEADOWBROOK INSURANCE (MIG, Financial): SVP - CFO Karen M Spaun Bought 5,000 Shares
SVP - CFO of MEADOWBROOK INSURANCE (MIG) Karen M Spaun bought 5,000 shares on 02/22/2011 at an average price of $10.2. MEADOWBROOK INS GROUP INC, through its subsidiaries, is engaged primarily in developing and managing Alternative Market risk management programs for defined client groups and their members. Meadowbrook Insurance has a market cap of $546.1 million; its shares were traded at around $10.26 with a P/E ratio of 9.7 and P/S ratio of 0.7. The dividend yield of Meadowbrook Insurance stocks is 1.6%. Meadowbrook Insurance had an annual average earning growth of 10.2% over the past 5 years.
Meadowbrook Insurance Group, Inc. reported improved full year and fourth quarter 2010 results. Meadowbrook Insurance Group, Inc. reported that net operating income for the year ended December 31, 2010increased 8.8% to $58.2 million, or $1.07 per diluted share, up from $53.5 million, or $0.93 per diluted share, for the comparable prior year period. Net income increased 13.4% to $59.7 million, or $1.10 per diluted share, compared to $52.7 million, or $0.92 per diluted share, in 2009.
Mutual Fund and Other Gurus that owns MIG: Chuck Royce of Royce& Associates, John Keeley of Keeley Fund Management, Mario Gabelli of GAMCO Investors.
SVP - CFO Karen M Spaun bought shares of MIG stock.
Director Jeffrey A Maffett, Director Merton J Segal, and SVP - Chief Actuary Stephen A Belden sold shares of MIG stock.
UGI Corp. (UGI, Financial): CFO Robert C Flexon Bought 5,000 Shares
CFO of UGI Corp. (UGI) Robert C Flexon bought 5,000 shares on 02/16/2011 at an average price of $32.06. UGI Corporation is a holding company that operates propanedistribution, gas and electric utility, energy marketing and related businesses through subsidiaries. Ugi Corp. has a market cap of $3.54 billion; its shares were traded at around $32.01 with a P/E ratio of 13.5 and P/S ratio of 0.6. The dividend yield of Ugi Corp. stocks is 3.1%. Ugi Corp. had an annual average earning growth of 9.4% over the past 10 years. GuruFocus rated Ugi Corp. the business predictability rank of 3-star.
Hedge Fund Gurus that owns UGI: Bruce Kovner of Caxton Associates, George Soros of Soros Fund Management LLC, Jim Simons of Renaissance Technologies LLC. Mutual Fund and Other Gurus that owns UGI: Diamond Hill Capital of Diamond Hill Capital Management Inc, Chuck Royce of Royce& Associates, Jeremy Grantham of GMO LLC, Mario Gabelli of GAMCO Investors.
President & CEO of AmeriGas Eugene V N Bissell, Chairman & CEO Lon R Greenberg, and President & COO John L Walsh sold shares of UGI stock.
GLATFELTER (GLT, Financial): SVP, CFO John P Jacunski Bought 5,000 Shares
SVP, CFO of GLATFELTER (GLT) John P Jacunski bought 5,000 shares on 02/23/2011 at an average price of $11.2. Glatfelter is a paper manufacturing company that manufactures printing papers and tobacco and other specialty papers. Glatfelter has a market cap of $561.8 million; its shares were traded at around $12.25 with a P/E ratio of 13.8 and P/S ratio of 0.4. The dividend yield of Glatfelter stocks is 2.9%. Glatfelter had an annual average earning growth of 0.3% over the past 10 years.
Glatfelter reported its financial results for the quarter and year ended December 31, 2010, including adjusted earnings of $0.31 per diluted share in the fourth quarter of 2010, compared to $0.33 per diluted share a year ago. Consolidated net sales for the 2010 fourth quarter totaled $376.2 million, a 24.9 percent increase compared with $301.1 million for the fourth quarter of 2009. On a GAAP basis, the Company reported net income of $15.3 million or $0.33 per diluted share, for the fourth quarter of 2010, compared with net income of $46.0 million or $1.00 per diluted share in the same quarter a year ago.
Hedge Fund Gurus that owns GLT: Paul Tudor Jones of The Tudor Group, Jim Simons of Renaissance Technologies LLC. Mutual Fund and Other Gurus that owns GLT: Third Avenue Management, Donald Smith of Donald Smith & Co.
SVP, CFO John P Jacunski and V. P. Global Supply Chain Mark A Sullivan bought shares of GLT stock.
Innospec Inc. (IOSP, Financial): Exec VP & CFO Ian Cleminson Bought 5,014 Shares
Exec VP & CFO of Innospec Inc. (IOSP) Ian Cleminson bought 5,014 shares during the past week at an average price of $26.94. Octel Corp. is a major manufacturer and distributor of fuel additives and other specialty chemicals. Innospec Inc. has a market cap of $642 million; its shares were traded at around $26.96 with a P/E ratio of 9.7 and P/S ratio of 0.9.
Innospec Inc. announced its financial results for the fourth quarter and full year ended December 31, 2010. Total net sales for the fourth quarter were $177.3 million, an 8% increase from $164.2 million in the corresponding period last year. Net income was $24.3 million, or $0.98 per diluted share, compared with a net loss of ($0.3) million, or ($0.01) per share, a year ago.
Hedge Fund Gurus that owns IOSP: Jim Simons of Renaissance Technologies LLC. Mutual Fund and Other Gurus that owns IOSP: Chuck Royce of Royce& Associates.
Exec VP & CFO Ian Cleminson, Group Financial Controller Mark Bracewell, and Exec VP, Business Operations Philip John Boon bought shares of IOSP stock.
For the complete list of stocks that bought by their CFOs, go to: Insider Buys.
